Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil's absorption is too variable for it to be a reliable reference drug.

Injectable treatments can effectively and safely improve hair growth in adults with androgenetic alopecia.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Different types of resting melanocyte stem cells have unique characteristics and vary in their potential to become other cells.

Teak leaf extract may effectively and safely promote hair growth in males with androgenic alopecia.

Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.

The study created a tool that mimics natural cell signals, which increased cell growth and could help with hair regeneration research.

A 20-year-old woman was found to have a rare ovarian tumor causing symptoms like acne and a low-pitched voice, which disappeared after the tumor was removed.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

PRP is a promising treatment for autoimmune hair loss but its exact workings are not fully understood.

Targeting CXXC5 and GSK-3β may help treat male pattern baldness.

The study developed accurate, precise, and environmentally friendly methods to measure Finasteride and Tadalafil in a new FDA-approved combination.

Keratin mutations cause skin diseases and could lead to new treatments.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Botulinum and tetanus neurotoxins are better understood now, with updated information on their effects and treatment.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Targeting a protein that blocks hair growth with microRNAs could lead to new hair loss treatments, but more research is needed.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Sox2 controls hair color by affecting pigment production in hair follicles.

Oncologists should better understand the unique impact of hair loss on Black breast cancer patients to offer more compassionate care.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Collagen from tilapia scales may improve hair and skin health by reducing stress and inflammation and encouraging hair growth.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

PRP is popular for hair restoration but needs better research methods to confirm its effectiveness and safety.

Quercetin-loaded nanoparticles protect human hair from UV-B damage.

Stem-cell therapy shows promise for skin conditions but needs more research.